2012 annual financial data

Karyopharm Therapeutics Inc. 2012 Operating margin

Karyopharm Therapeutics Inc. 2012 operating margin with verified reported value…

Direct answer

Operating margin was -2,506.31%.

Operating income was -15,890,000 USD and net income was -15,888,000 USD.
Operating cash flow was -15,509,000 USD.

Get free Karyopharm Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
634,000 USD
Operating income
-15,890,000 USD
Net income
-15,888,000 USD
Operating cash flow
-15,509,000 USD